MAP4K4
protein-codingmitogen-activated protein kinase kinase kinase kinase 4, the group of Mitogen-activated protein kinase kinase kinase kinases
Gene summary
The protein encoded by this gene is a member of the serine/threonine protein kinase family. This kinase has been shown to specifically activate MAPK8/JNK. The activation of MAPK8 by this kinase is found to be inhibited by the dominant-negative mutants of MAP3K7/TAK1, MAP2K4/MKK4, and MAP2K7/MKK7, which suggests that this kinase may function through the MAP3K7-MAP2K4-MAP2K7 kinase cascade, and mediate the TNF-alpha signaling pathway. Alternatively spliced transcript variants encoding different isoforms have been identified. [provided by RefSeq, Jul 2008]
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~197.8 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: AD
Disease ID:MONDO:0021060
Submitter: PanelApp Australia
Inheritance Pattern: AD
Disease ID:MONDO:0100038
Submitter: G2P
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to MAP4K4 variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_001395002.1. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 6 | 2 | 2 | 10 | ||
| missense | 2 | 6 | 188 | 9 | 205 | |
| nonsense | 1 | 3 | 3 | 7 | ||
| start loss | 0 | |||||
| frameshift | 1 | 2 | 8 | 11 | ||
| splice donor/acceptor (+/-2bp) | 1 | 12 | 13 | |||
| Total | 4 | 12 | 217 | 11 | 2 | 246 |
Highest pathogenic variant AF is 0.000009369378
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_001381931.1 | 33 | MANE Select | |
| Ensembl | ENSP00000313644.6 | 33 | MANE Select | |
| RefSeq | NP_001229488.1 | 30 | Standard | |
| RefSeq | NP_001229489.1 | 31 | Standard |
Model Organisms & Knockout Phenotypes
Observed phenotypic effects in mouse and zebrafish models
| Gene / Model | Organism | Observed Phenotype |
|---|---|---|
| map4k4 | Danio rerio | Structure: gastrulation Quality: disrupted abnormal |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Pathways ConsensusPathDB
- MAPK signaling pathway - Homo sapiens (human)
- EGF-Core
- Oxidative Stress Induced Senescence
- MAPK Signaling Pathway
- Angiopoietin Like Protein 8 Regulatory Pathway
Biological Process
- MAPK cascade
- negative regulation of cell-matrix adhesion
- protein phosphorylation
- signal transduction by protein phosphorylation
- microvillus assembly
Molecular Function
- creatine kinase activity
- protein serine/threonine kinase activity
- protein binding
- ATP binding
- microtubule binding
Cellular Component
- cytoplasm
- focal adhesion
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000347699
- Coding exons
- 30
- Length
- 197838
- Individuals with no LoFs
- 124644
- Homozygous LoFs
- 0
- Heterozygous LoFs
- 12
- Defined
- 124656
- p
- 0.0000481
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | 4.74 | 320 | 664 | 0.482 | 0.0000369 | 8035 |
| Missense (PolyPhen) | 105 | 235.05 | 0.44672 | 2791 | ||
| Synonymous | 0.755 | 229 | 244 | 0.939 | 0.0000134 | 2344 |
| Loss of Function | 7.29 | 7 | 75.3 | 0.0930 | 0.00000445 | 857 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0.000066 | 0.000065 | rare |
| Latino/Admixed American | 0.000059 | 0.000058 | rare |
| Ashkenazi Jewish | 0.000099 | 0.000099 | rare |
| East Asian | 0 | 0.0 | absent |
| Finnish | 0 | 0.0 | absent |
| European (Non-Finnish) | 0.000053 | 0.000053 | rare |
| South Asian | 0.000038 | 0.000033 | rare |
| Other | 0.00017 | 0.00017 | rare |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: Serine/threonine kinase that may play a role in the response to environmental stress and cytokines such as TNF-alpha. Appears to act upstream of the JUN N-terminal pathway. Phosphorylates SMAD1 on Thr-322. {ECO:0000269|PubMed:21690388, ECO:0000269|PubMed:9890973}.;
Recessive Scores
- pRec
- 0.226
Intolerance Scores
- LoFtool
- 0.258
- RVIS EVS
- -1.44
- RVIS percentile EVS
- 3.95
Essentials
- Essential (CRISPR)
- N
- Essential (CRISPR2)
- N
- Essential (gene trap)
- N
- Indispensability pred.
- E
- Indispensability score
- 0.961
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |